Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)
Close on Nov 17, 2026Market cap $666.15MP/E –Yield –
Fulgent Genetics cash
Cash and short-term investments held at the end of each period.
Fulgent Genetics's cash was $257.03M at Jun 30, 2026. For fiscal 2025 it was $336.08M, up 30.1% from the year before. Over ten years it grew 92.2% a year on average. The highest annual figure on record is $336.08M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $336.08M | +30.1% |
| FY2024 | Dec 31, 2024 | $258.24M | +164.9% |
| FY2023 | Dec 31, 2023 | $97.47M | +22.6% |
| FY2022 | Dec 31, 2022 | $79.51M | -51.8% |
| FY2021 | Dec 31, 2021 | $164.89M | -44.9% |
| FY2020 | Dec 31, 2020 | $299.37M | +959.0% |
| FY2019 | Dec 31, 2019 | $28.27M | -8.9% |
| FY2018 | Dec 31, 2018 | $31.03M | +17.2% |
| FY2017 | Dec 31, 2017 | $26.48M | +235.4% |
| FY2016 | Dec 31, 2016 | $7.90M | +1514.9% |
| FY2015 | Dec 31, 2015 | $489.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $257.03M | +192.5% |
| Q1 FY2026 | Mar 31, 2026 | $276.30M | +310.7% |
| Q4 FY2025 | Dec 31, 2025 | $336.08M | +30.1% |
| Q3 FY2025 | Sep 30, 2025 | $117.64M | +102.7% |
| Q2 FY2025 | Jun 30, 2025 | $87.88M | +35.0% |
| Q1 FY2025 | Mar 31, 2025 | $67.28M | +23.1% |
| Q4 FY2024 | Dec 31, 2024 | $258.24M | +164.9% |
| Q3 FY2024 | Sep 30, 2024 | $58.04M | -31.0% |
| Q2 FY2024 | Jun 30, 2024 | $65.11M | +11.6% |
| Q1 FY2024 | Mar 31, 2024 | $54.68M | -17.4% |
| Q4 FY2023 | Dec 31, 2023 | $97.47M | +22.6% |
| Q3 FY2023 | Sep 30, 2023 | $84.08M | -50.2% |
| Q2 FY2023 | Jun 30, 2023 | $58.35M | -58.0% |
| Q1 FY2023 | Mar 31, 2023 | $66.17M | -81.3% |
| Q4 FY2022 | Dec 31, 2022 | $79.51M | -51.8% |
| Q3 FY2022 | Sep 30, 2022 | $168.77M | -21.5% |
| Q2 FY2022 | Jun 30, 2022 | $138.78M | +38.1% |
| Q1 FY2022 | Mar 31, 2022 | $353.07M | +133.1% |
| Q4 FY2021 | Dec 31, 2021 | $164.89M | -44.9% |
| Q3 FY2021 | Sep 30, 2021 | $214.88M | +186.8% |
| Q2 FY2021 | Jun 30, 2021 | $100.46M | +379.3% |
| Q1 FY2021 | Mar 31, 2021 | $151.46M | +454.2% |
| Q4 FY2020 | Dec 31, 2020 | $299.37M | +959.0% |
| Q3 FY2020 | Sep 30, 2020 | $74.94M | +133.3% |
| Q2 FY2020 | Jun 30, 2020 | $20.96M | -22.3% |
| Q1 FY2020 | Mar 31, 2020 | $27.33M | -7.1% |
| Q4 FY2019 | Dec 31, 2019 | $28.27M | -8.9% |
| Q3 FY2019 | Sep 30, 2019 | $32.12M | -1.5% |
| Q2 FY2019 | Jun 30, 2019 | $26.99M | +638.5% |
| Q1 FY2019 | Mar 31, 2019 | $29.43M | +458.0% |
| Q4 FY2018 | Dec 31, 2018 | $31.03M | +17.2% |
| Q3 FY2018 | Sep 30, 2018 | $32.60M | +244.0% |
| Q2 FY2018 | Jun 30, 2018 | $3.65M | -68.2% |
| Q1 FY2018 | Mar 31, 2018 | $5.27M | -21.7% |
| Q4 FY2017 | Dec 31, 2017 | $26.48M | +235.4% |
| Q3 FY2017 | Sep 30, 2017 | $9.48M | +15.5% |
| Q2 FY2017 | Jun 30, 2017 | $11.47M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.73M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.90M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.21M | – |
See a number that looks wrong?